Skip to content
Search

Latest Stories

Not enough evidence that taking vitamin D can treat or prevent coronavirus: NICE

A NICE-led study into vitamin D and Covid-19 has concluded there is 'not enough evidence' that taking the supplement can treat or prevent the disease.

The National Institute for Health and Care Excellence (NICE) said more research,  particularly of high-quality randomised controlled trials, was needed as it reviewed, in collaboration with Public Health England, and the Scientific Advisory Committee on Nutrition, some studies that suggested vitamin D could help in the fight against coronavirus.


However, the new guidance, published today (Dec 17) states that people should continue to follow the current government advice on daily vitamin D supplementation to maintain bone and muscle health during the Covid-19 pandemic.

Dr Paul Chrisp, guidelines director at NICE, said: “While there is insufficient evidence to recommend vitamin D for the prevention or treatment of Covid-19 at this time, we encourage people to follow government advice on taking the supplement throughout the autumn and winter period.

“As research continues on the impact of vitamin D on COVID-19, we are continuing to monitor evidence as it is published and will review and update the guidance if necessary.”

It is recommended that everyone should continue taking a daily dose of 10 microgram vitamin D supplement from October to early March, which is safe and effective at maintaining healthy vitamin D blood levels. Although sunlight exposure is the major source of vitamin D for most people during summer months, it can also be obtained from the diet or supplements.

The noted that many people have been indoors due to the pandemic, therefore it’s even more important this year to take a vitamin D supplement.

It said some people are more at risk of not having enough vitamin D even in spring and summer, including those with dark skin, those who are not outdoors often, those in care homes, and those who cover up most of the skin when outdoors. "We advise these people to take a vitamin D supplement all year round."

Professor Ian Young, chair of the Scientific Advisory Committee on Nutrition, which advises PHE and other UK government organisations on nutrition and related health matters, said: “SACN has worked closely with NICE and PHE to consider the available evidence from recent studies on vitamin D in relation to Covid-19. This evidence review confirms that currently there is not enough available evidence to determine that there is a causal relationship between vitamin D and Covid-19.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less